• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞羟基脲治疗中父母风险评估调查里抽象数字与视觉风险描述的比较

Comparing abstract numerical and visual depictions of risk in survey of parental assessment of risk in sickle cell hydroxyurea treatment.

作者信息

Patterson Chavis A, Barakat Lamia P, Henderson Phyllis K, Nall Faith, Westin Anna, Dampier Carlton D, Hsu Lewis L

机构信息

Marian Anderson Comprehensive Sickle Cell Center, St. Christopher's Hospital for Children, Philadelphia, PA 19134, USA.

出版信息

J Pediatr Hematol Oncol. 2011 Jan;33(1):4-9. doi: 10.1097/MPH.0b013e3181f46884.

DOI:10.1097/MPH.0b013e3181f46884
PMID:21178705
Abstract

Communicating risk is an important activity in medical decision-making; yet, numeracy is not a universal skill among the American public. We examined the hypothesis that numerical risk information about the use of hydroxyurea for children with sickle cell disease would elicit different risk assessment responses when visual depictions were used instead of abstract numbers and depending on the disease severity. Parents of 81 children with sickle cell disease participated in a survey in which hydroxyurea was first described as carrying a certain chance of risk for both birth defects and cancer. Then, the parents indicated the highest risk at which they would hypothetically consent to the treatment to help their child. Risk presentations were repeated with abstract numerical, pie graph, and 1000 people histogram formats. The χ analyses comparing high-risk to low-risk assessment across presentation formats showed high consistency between visual depictions but low consistency of abstract numerical with visual depictions. The parents of children with SC and other less severe types of SCD were less willing to accept higher risk than those with SS when the data were presented numerically. Given earlier concerns about poor "numeracy" in the US population, visual depictions of risk could be an effective tool for routine communication in health education and medical decision-making.

摘要

传达风险是医疗决策中的一项重要活动;然而,具备数字运算能力并非美国公众普遍拥有的技能。我们检验了这样一个假设:对于镰状细胞病患儿使用羟基脲的数值风险信息,当使用直观描述而非抽象数字呈现,且取决于疾病严重程度时,会引发不同的风险评估反应。81名镰状细胞病患儿的家长参与了一项调查,在调查中,羟基脲首先被描述为对出生缺陷和癌症均有一定的风险几率。然后,家长们指出在假设情况下他们会同意为帮助孩子接受治疗的最高风险水平。风险呈现以抽象数字、饼状图和千人群直方图形式重复进行。比较不同呈现形式下高风险与低风险评估的χ分析表明,直观描述之间具有高度一致性,但抽象数字与直观描述之间的一致性较低。当以数字形式呈现数据时,与患有SS型镰状细胞病的患儿家长相比,患有SC型及其他病情较轻类型镰状细胞病的患儿家长更不愿意接受更高的风险。鉴于此前对美国人群“数字运算能力”较差的担忧,风险的直观描述可能是健康教育和医疗决策中常规沟通的有效工具。

相似文献

1
Comparing abstract numerical and visual depictions of risk in survey of parental assessment of risk in sickle cell hydroxyurea treatment.镰状细胞羟基脲治疗中父母风险评估调查里抽象数字与视觉风险描述的比较
J Pediatr Hematol Oncol. 2011 Jan;33(1):4-9. doi: 10.1097/MPH.0b013e3181f46884.
2
Therapy preference and decision-making among patients with severe sickle cell anemia and their families.重度镰状细胞贫血患者及其家庭的治疗偏好与决策
Pediatr Blood Cancer. 2007 Jun 15;48(7):705-10. doi: 10.1002/pbc.20903.
3
Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.严重小儿镰状细胞病的临床并发症及羟脲的影响。
Pediatr Blood Cancer. 2011 Jan;56(1):90-4. doi: 10.1002/pbc.22822. Epub 2010 Oct 4.
4
Bone marrow transplantation for sickle cell disease. A study of parents' decisions.镰状细胞病的骨髓移植。一项关于父母决策的研究。
N Engl J Med. 1991 Nov 7;325(19):1349-53. doi: 10.1056/NEJM199111073251905.
5
Parents' assessment of risk in sickle cell disease treatment with hydroxyurea.父母对羟基脲治疗镰状细胞病风险的评估。
J Pediatr Hematol Oncol. 2005 Dec;27(12):644-50. doi: 10.1097/01.mph.0000193488.72989.c4.
6
Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes.镰状细胞病患儿的长期羟基脲治疗:耐受性及临床结果
Haematologica. 2006 Jan;91(1):125-8.
7
Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.羟基脲治疗镰状细胞病成人的临床随访。
Acta Haematol. 2011;125(3):145-52. doi: 10.1159/000322248. Epub 2010 Dec 24.
8
Parental attitudes toward research participation in pediatric sickle cell disease.父母对儿科镰状细胞病研究参与的态度。
Pediatr Blood Cancer. 2010 Jul 15;55(1):129-33. doi: 10.1002/pbc.22450.
9
Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.镰状细胞病中的羟基脲——对印度单倍型临床药理疗效的研究
Blood Cells Mol Dis. 2009 Jan-Feb;42(1):25-31. doi: 10.1016/j.bcmd.2008.08.003. Epub 2008 Oct 26.
10
Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease.羟基脲的依从性及其与镰状细胞病医疗补助受种者相关结局的关系。
Am J Hematol. 2011 Mar;86(3):273-7. doi: 10.1002/ajh.21968. Epub 2011 Feb 15.

引用本文的文献

1
The challenge of eliciting opinions of gene therapy for SCD.征求镰状细胞病基因治疗意见面临的挑战。
Blood Adv. 2023 Dec 12;7(23):7369-7370. doi: 10.1182/bloodadvances.2023011606.
2
Patient Perspectives on Gene Transfer Therapy for Sickle Cell Disease.镰状细胞病患者对基因转移治疗的看法。
Adv Ther. 2017 Aug;34(8):2007-2021. doi: 10.1007/s12325-017-0587-7. Epub 2017 Jul 17.
3
Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
羟基脲的依从性、健康相关生活质量领域以及患者对镰状细胞病和羟基脲的认知:一项针对青少年和青年的横断面研究
Health Qual Life Outcomes. 2017 Jul 5;15(1):136. doi: 10.1186/s12955-017-0713-x.